Zum Hauptinhalt springen

international

16. November 2020 | international

COVID19 pandemic and people with opioid use disorder: innovation to reduce risk.

COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Vecchio S, Ramella R, Drago A, Carraro D, Littlewood R, Somaini L. Psychiatry Res. 2020 Jul;289:113047. doi: 10.1016/j.psychres.2020.113047. Epub 2020 Apr…

16. November 2020 | international

USA. Using telehealth to boost treatment for substance-use disorder

USA. Using telehealth to boost treatment for substance-use disorder Edwin Chapman, MD, a District of Columbia internist, understands that “innovation” is not just a buzzword conjuring up advancements such as stem cell research or cancer-curing trea…

16. November 2020 | international

Revising our attitudes towards agonist medications and their diversion in a time of pandemic.

Revising our attitudes towards agonist medications and their diversion in a time of pandemic. Del Pozo B, Rich JD. J Subst Abuse Treat. 2020 Dec;119:108139. doi: 10.1016/j.jsat.2020.108139. Epub 2020 Sep 21. PMID: 33138924; PMCID: PMC7…

16. November 2020 | international

COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns.

COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns. Mellis AM, Potenza MN, Hulsey JN. J Subst Abuse Treat. 2020 Oct 21:108180. doi: 10.1016/j.jsat.2020.108180. Epub ahead of print. P…

16. November 2020 | international

Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond.

Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond. Bergman BG, Kelly JF. J Subst Abuse Treat. 2020 Oct 4:108152. doi: 10…

16. November 2020 | international

Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients.

Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients. Pandit PM, Bhatia G, Sarkar S. J Subst Abuse Treat. 2020 Dec;119:108128. doi: 10.1016/j.jsat.2020.108128. Epub 2020 Sep 18. PMID: 33138923; PMCID…

16. November 2020 | international

Access to substance use disorder treatment during COVID-19: Implications from reduced local jail populations

Access to substance use disorder treatment during COVID-19: Implications from reduced local jail populations. Aslim EG, Mungan MC. J Subst Abuse Treat. 2020 Dec;119:108147. doi: 10.1016/j.jsat.2020.108147. Epub 2020 Sep 25. PMID: 33138…

Weitere
akutelle Informationen
zu den Themengebieten